Aug 14, 2025 13:16
CLNN - Clene Inc. Common Stock
| Day | 1m | 10m | 60m | PreMarket | Market | AfterHours | Gap |
|---|---|---|---|---|---|---|---|
| 8.78 0.46 (5.24%) | --- | 0.02 (0.22%) | -0.2 (-2.12%) | --- | 0.46 (5.24%) | -0.05 (-0.58%) | -0.05 (-0.58%) |
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.
Category:
PHARMACEUTICAL PREPARATIONS
Market Period:
Market
Earnings & Ratios
- Basic EPS:
- -0.78
- Diluted EPS:
- Basic P/E:
- -11.8462
- Diluted P/E:
- RSI(14) 1m:
- 30.0
- VWAP:
- 9.25
- RVol:
Events
| Period | Kind | Movement | Occurred At |
|---|
Related News
Sep 03, 2024 12:00
Jul 17, 2024 11:03
Jul 09, 2024 16:11
Jun 24, 2024 12:00
Jun 21, 2024 11:09
Jun 18, 2024 11:00
May 28, 2024 11:30
May 23, 2024 14:01
May 14, 2024 12:00